Alternative eradication regimens for infection in Indonesian regions with high metronidazole and levofloxacin resistance (Q61805254)

1

object named as

Muhammad Miftahussurur

0 references

Langgeng Agung Waskito

Yudith Annisa Ayu Rezkitha

2

object named as

Langgeng Agung Waskito

0 references

8

object named as

Yudith Annisa Ayu Rezkitha

0 references

author name string

Ari Fahrial Syam

3

0 references

Iswan Abbas Nusi

4

0 references

Gontar Siregar

5

0 references

Marselino Richardo

6

0 references

Achmad Fuad Bakry

7

0 references

I Dewa Nyoman Wibawa

9

0 references

Yoshio Yamaoka

Infection and Drug Resistance

10

0 references

language of work or name

English

0 references

publication date

2019

0 references

published in

0 references

volume

12

0 references

page(s)

345-358

0 references

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

start time

1 January 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial

1 reference

12 December 2020

Pharmacology and toxicity of furazolidone in man and animals: some recent research

1 reference

12 December 2020

Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020

Antimicrobial activity of rifabutin

1 reference

12 December 2020

In vivo disposition and metabolism by liver and enterocyte microsomes of the antitubercular drug rifabutin in rats

1 reference

12 December 2020

Antibacterial Activities and Inhibitory Effects of Sitafloxacin (DU-6859a) and Its Optical Isomers against Type II Topoisomerases

1 reference

12 December 2020

Contribution of rpoB Mutations to Development of Rifamycin Cross-Resistance in Mycobacterium tuberculosis

1 reference

12 December 2020

In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657.

1 reference

12 December 2020

Rifampin and rifabutin resistance mechanism in Helicobacter pylori

1 reference

12 December 2020

Pharmacological, therapeutic and toxicological properties of furazolidone: some recent research

1 reference

12 December 2020

In vitro activity of rifabutin against strains of Helicobacter pylori resistant to metronidazole and clarithromycin

1 reference

12 December 2020

Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE).

1 reference

12 December 2020

Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance

1 reference

12 December 2020

Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin

1 reference

12 December 2020

Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential

1 reference

12 December 2020

Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders

1 reference

12 December 2020

Eradication of Helicobacter pylori: are rifaximin-based regimens effective?

1 reference

12 December 2020

Nitrofuran-based regimens for the eradication of Helicobacter pylori infection

1 reference

12 December 2020

Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile

1 reference

12 December 2020

"Rescue" regimens after Helicobacter pylori treatment failure

1 reference

12 December 2020

Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation

1 reference

12 December 2020

Is Furazolidone Therapy for Helicobacter pylori Effective and Safe?

1 reference

12 December 2020

Sitafloxacin activity against Helicobacter pylori isolates, including those with gyrA mutations

1 reference

12 December 2020

Genome dynamics in major bacterial pathogens.

1 reference

12 December 2020

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

1 reference

12 December 2020

Furazolidone induced oxidative DNA damage via up-regulating ROS that caused cell cycle arrest in human hepatoma G2 cells

1 reference

12 December 2020

Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile.

1 reference

12 December 2020

High Helicobacter pylori Resistance to Metronidazole but Zero or Low Resistance to Clarithromycin, Levofloxacin, and Other Antibiotics in Malaysia

1 reference

12 December 2020

Helicobacter pylori resistance to rifabutin in the last 7 years.

1 reference

12 December 2020

Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline

1 reference

12 December 2020

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

1 reference

12 December 2020

Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies.

1 reference

12 December 2020

Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.

1 reference

12 December 2020

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

1 reference

12 December 2020

The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam

1 reference

12 December 2020

A new approach for elimination of gastric cancer deaths in Japan

1 reference

12 December 2020

Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps

1 reference

12 December 2020

Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection

1 reference

12 December 2020

The effectiveness of endoscopic retrograde cholangiopancreatography in the management of patients with jaundice at Cipto Mangunkusumo Hospital, Jakarta

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition

1 reference

12 December 2020

Second and third line treatment options for Helicobacter pylori eradication

1 reference

12 December 2020

Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials

1 reference

12 December 2020

Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis.

1 reference

12 December 2020

Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice

1 reference

12 December 2020

Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection

1 reference

12 December 2020

Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion

1 reference

12 December 2020

Susceptibility of Helicobacter pylori to Levofloxacin and Rifampicin in Israel

1 reference

12 December 2020

Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.

1 reference

12 December 2020

Prevalence of Primary Resistance of Helicobacter pylori to Clarithromycin and Levofloxacin in Southern Spain.

1 reference

12 December 2020

Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review

1 reference

12 December 2020

Risk Factors and Prevalence of Helicobacter pylori in Five Largest Islands of Indonesia: A Preliminary Study.

1 reference

12 December 2020

Review article: the global emergence of Helicobacter pylori antibiotic resistance.

1 reference

12 December 2020

Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance

1 reference

12 December 2020

Preliminary Evaluation of a Sitafloxacin-Containing Regimen for Relapsed or Refractory Pulmonary Mycobacterium avium Complex Disease

1 reference

12 December 2020

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

1 reference

12 December 2020

Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.

1 reference

12 December 2020

Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations

1 reference

12 December 2020

Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial

1 reference

12 December 2020

Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis

1 reference

12 December 2020

Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients

1 reference

12 December 2020

Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta-analysis.

1 reference

12 December 2020

Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens.

1 reference

12 December 2020